NCT00414817

Brief Summary

Inhaled corticosteroids (ICS) are often prescribed as a treatment for asthma. However, many individuals who take these medications do not adhere to their prescribed treatment regimen. The purpose of this study is to evaluate the effectiveness of a telephone-based program at improving medication adherence among individuals with asthma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14,064

participants targeted

Target at P75+ for not_applicable asthma

Timeline
Completed

Started Jun 2007

Typical duration for not_applicable asthma

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 22, 2006

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2007

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2009

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2009

Completed
7.3 years until next milestone

Results Posted

Study results publicly available

January 30, 2017

Completed
Last Updated

January 30, 2017

Status Verified

December 1, 2016

Enrollment Period

1.8 years

First QC Date

December 20, 2006

Results QC Date

July 23, 2015

Last Update Submit

December 6, 2016

Conditions

Keywords

Inhaled CorticosteroidsICSAdherence

Outcome Measures

Primary Outcomes (1)

  • Modified Medication Possession Ratio

    We used a modification of the Medication Possession Ratio (MPR) as our primary outcome measure. The MPR is computed as the number of days' supply of medication dispensed during a given time window divided by the time between the first dispensing in the window and the end of the window. Our modified MPR (mMPR) also accounted for medication that was on hand at the start of the window and ignored any days' supply that would extend beyond the end of the window. The MPR, and by extension the mMPR, assumes that medications were used as directed and that a new inhaled corticosteroid canister was not started until any medication on hand was exhausted.

    Measured over 19 months

Secondary Outcomes (2)

  • Juniper Asthma Quality of Life Questionnaire (Global Score)

    Measured at 19 months

  • Rate of Acute Health Care Visits for Asthma

    Measured over 19 months of follow-up

Study Arms (2)

Automated Phone-Based Refill Reminders

EXPERIMENTAL

Intervention Arm: Participants randomly assigned to this study arm may receive up to 8 automated phone calls from the BREATH EASY Medication Reminder Program over the course of the 19 month intervention period.

Behavioral: Automated Phone-Based Refill Reminders

Usual Care

NO INTERVENTION

Usual Care: Participants randomly assigned to this arm received the same introductory letter as those in the intervention arm, giving them the opportunity to opt out, but were subsequently selected to be in the "usual care" study arm, and therefore, receive no intervention.

Interventions

The BREATHE EASY Medication Reminder Program uses interactive voice recognition phone technology to offer timely reminders to patients to refill their ICS medication, educational messages about ICS, and may offer to transfer them to a refill line or to speak with a pharmacist if they have questions.

Also known as: The BREATHE EASY Medication Reminder Program
Automated Phone-Based Refill Reminders

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Received treatment for asthma in the year prior to study entry
  • Received at least one respiratory medication at a Kaiser Permanente Northwest (KPNW) or Kaiser Permanente Hawaii (KPH) outpatient pharmacy in the year prior to study entry
  • Continuous Kaiser Permanente membership from the year prior to study entry through study entry
  • Willing to participate in the study

You may not qualify if:

  • Excluded from primary analyses if fewer than three months of follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Center for Health Research/KPH

Honolulu, Hawaii, 96817, United States

Location

Center for Health Research-KPNW

Portland, Oregon, 97227, United States

Location

Related Publications (3)

  • Vollmer WM, Xu M, Feldstein A, Smith D, Waterbury A, Rand C. Comparison of pharmacy-based measures of medication adherence. BMC Health Serv Res. 2012 Jun 12;12:155. doi: 10.1186/1472-6963-12-155.

    PMID: 22691240BACKGROUND
  • Vollmer WM, Feldstein A, Smith DH, Dubanoski JP, Waterbury A, Schneider JL, Clark SA, Rand C. Use of health information technology to improve medication adherence. Am J Manag Care. 2011 Dec;17(12 Spec No.):SP79-87.

  • Schneider J, Waterbury A, Feldstein A, Donovan J, Vollmer WM, Dubanoski J, Clark S, Rand C. Maximizing acceptability and usefulness of an automated telephone intervention: Lessons from a developmental mixed-methods approach. Health Informatics J. 2011 Mar;17(1):72-88. doi: 10.1177/1460458210391220.

Related Links

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Results Point of Contact

Title
Dr. William Vollmer, Senior Investigator
Organization
Kaiser Permanente, Center for Health Research

Study Officials

  • William M. Vollmer, PhD

    Center for Health Research/KPNW

    PRINCIPAL INVESTIGATOR
  • Cynthia Rand, PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR
  • Joan Dubanoski, PhD

    Center for Health Research/KPH

    PRINCIPAL INVESTIGATOR
  • Adrianne Feldstein, MD

    Center for Health Research/KPNW

    PRINCIPAL INVESTIGATOR
  • David Smith, PhD

    Center for Health Research/KPNW

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2006

First Posted

December 22, 2006

Study Start

June 1, 2007

Primary Completion

April 1, 2009

Study Completion

October 1, 2009

Last Updated

January 30, 2017

Results First Posted

January 30, 2017

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations